RE: 18to20 I am a significant shareholder who at least knows that our current leadeership has continued to make possitive strides forward in spite of the fact that they have had serious unanticipated setbacks. Am I frustrated at the pace of advancement? Certainly! Regardless, I have far more reason to continue trusting the current leadership which introduced and is developing the MCC platform drugs, Econiche, as well as the new vaccine plant then to put my faith in a dissident group of Wells led stockholders who know nothing about running this company.
That describes my agenda, what is yours? You apparently would prefer to put your faith behind an unknown dissident group just for the sake of change, regardless of the possible outcome, and to post your support for the merits of this would be takeover relentlessly on this board. Perhaps in another year, I will be in your camp if no obvious headway is acheived. But Bioniche is far too close to a conclusion on all of these fronts to force this issue at this time. Don't you think the specific timing of this takeover appears highly suspicioius?
I have a significant portion of my portfolio with this stock, and you sound like a mouthpiece for the dissident takeover group to me. If you are also a shareholder, what makes you so certain this is the right move at this time or that this group can be trusted?
The only good that I see from this attempted coop is that this will hopefully force the issue with Bioniche to share more information with us and to consumate deals to move us forward more quickly now. However, as SWNE just stated in his last post, "This will rush Bioniche to make a deal, and we all know a rushed deal is never good." So, I would prefer this group would put this takeover attempt on hold for 6 months and let Bioniche move forward unencumbered to completion with the plant validation, Urocidin partnerships, Econiche, Oncocidin, Sin Susto, Immunocidin, etc. etc...